Articles

Prognosis of patients with core binding factor acute myeloid leukemia after first relapse

Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
Hematology Division, Metropolitan Ohtsuka Hospital, Tokyo, Japan
Division of Biostatistics, Tohoku University Graduate School of Medicine, Miyagi, Japan
Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan
Department of Hematology, Saiseikai Maebashi Hospital, Maebashi, Japan
Department of Hematology, Sasebo City General Hospital, Sasebo, Japan
Division of Hematology and Oncology, Yokohama City Seibu Hospital, St. Marianna University School of Medicine, Yokohama, Japan
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
Stem Cell Transplantation Center, Hokkaido University Hospital, Sapporo, Japan
Department of Hematology, Rinku General Medical Center, Osaka, Japan
Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan
Division of Hematology, Ehime Prefectural Central Hospital, Matsuyama, Japan
Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan
Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Japan
Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan
Division of Hematology and Oncology, St. Marianna University School of Medicine, Kanagawa, Japan
Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
Vol. 98 No. 10 (2013): October, 2013 https://doi.org/10.3324/haematol.2012.078030